{"id":"W2151082560","doi":"10.1093/annonc/mdu456","title":"Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2","year":2014,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":568,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hôpital du Saint-Sacrement; Sunnybrook Health Science Centre; University of Toronto","funders":"Novartis Pharmaceuticals Corporation","keywords":"Medicine; Exemestane; Human Epidermal Growth Factor Receptor 2; Everolimus; Oncology; Internal medicine; Hormone receptor; Breast cancer; Cancer research; Cancer; Aromatase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004370143,0.0005397518,0.001643782,0.000176005,0.0001935874,0.00001346755,0.0003425198,0.0003844004,0.000322298],"category_scores_gemma":[0.0005505847,0.0005082938,0.0003498594,0.0002099389,0.0004801385,0.0003804804,0.0001130224,0.0004209298,0.00002368018],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004670301,"about_ca_system_score_gemma":0.0004472021,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002070168,"about_ca_topic_score_gemma":0.0003155833,"domain_scores_codex":[0.9963523,0.000340002,0.001054734,0.0009007655,0.0004618563,0.0008902976],"domain_scores_gemma":[0.9952018,0.001589344,0.0009393453,0.0005474329,0.001334639,0.0003874701],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1136911,0.001390581,0.002692879,0.0002318329,0.002218731,0.00003147854,0.00527135,0.0003700042,0.3965859,0.002771002,0.01446049,0.4602846],"study_design_scores_gemma":[0.09179001,0.02004953,0.5504739,0.0008658407,0.0004381523,0.00007336158,0.001137575,0.0003817494,0.1871324,0.008502736,0.1371137,0.00204099],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9635448,0.001010378,0.001841237,0.01806454,0.00110147,0.001663294,0.009624958,0.000184961,0.002964386],"genre_scores_gemma":[0.9879792,0.0007705692,0.005833525,0.002502189,0.001226636,0.0002392852,0.0007613286,0.0001153114,0.0005719418],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5477811,"threshold_uncertainty_score":0.9997368,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0499435101726918,"score_gpt":0.3632289122475997,"score_spread":0.313285402074908,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}